First Preloaded Toric Available in the United States and Monofocal Option Combine Consistent IOL Delivery with Outstanding Visual Outcomes of enVista® LAVAL, QC, Oct. 27, 2020 /PRNewswire ...

LAVAL, QC, Oct. 6, 2020 /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that three poster ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced ...

VAUGHAN, ON and TEL AVIV, Israel, July 28, 2022/ PRNewswire/-- Bausch+ Lomb Corporation, a leading global eye health company dedicated to helping people see better to live better, and Sanoculis ...

Social Media Initiative Includes Donation to Prevent Blindness' Sight-Saving Fund BRIDGEWATER, N.J. and CHICAGO, Feb. 1, 2022 /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of ...

Valeant Pharmaceuticals International's $8.7 billion deal for Bausch & Lomb Holdings, the eye-care company owned by Warburg Pincus, positions Canada's largest drugmaker to compete globally in the ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Bausch + Lomb Announces Fourth-Quarter and ...

Innovations in 170-year-old Bausch + Lomb’s pipeline include a biomimetic contact lens, a myopia control solution for children and revamped pharmaceutical products targeting unmet eye health needs.